NCT02439853
- Conditions
- Aphasia, Aphasia, Primary Progressive, Brain Diseases, +21 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
Clinical trial condition
Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.
NCT02439853
NCT00604591
NCT06226064
NCT03682185
NCT05581771
NCT04098406
NCT04797845
NCT02017912
NCT03516994
NCT00243932